Free Daily Podcast Summary
Pharma Market Access Insights - from Petauri Evidence: Daily Summaries Delivered
by Petauri Evidence
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Apr 21, 20261h 0m
Designing a Global Market Access Strategy Built for MFN
Send us Fan Mail How will Most Favored Nation (MFN) pricing reshape global pharmaceutical strategy? What do emerging Centers for Medicare & Medicaid Service (CMS) models such as GENEROUS, GLOBE, and GUARD mean for launch planning, pricing corridors, and payer expectations worldwide? How should global market access teams prepare for a more transparent and tightly connected pricing environment? MFN reform is already influencing how companies plan, price, and launch medicines around the worl...
- Apr 2, 202656 min
LATAM Market Access Unlocked: Insights from Argentina, Brazil, Colombia, and Mexico
Send us Fan Mail How do LATAM healthcare markets differ and what do these differences mean for Pharma and Medtech launch planning? What should global market access teams know to support affiliates in Argentina, Brazil, Colombia, and Mexico? How do evidence requirements, access routes, and payer expectations vary across the region? For global market access teams planning for launch in Latin America (LATAM), understanding the diversity and complexity of this region is essential. Healthcare sys...
- Nov 17, 202531 min
The Evolving NHS – An ICS Chief Pharmacist’s Perspective
Send us Fan Mail What does the evolving NHS landscape look like through the eyes of a Chief Pharmacist, and how are integrated care system (ICS) pharmacy teams responding? In this Petauri Evidence NHS Whispers session, we put your questions to Yousaf Ahmad (Chief Pharmacist and Director of Medicines Optimisation, Frimley ICS), as he shares how he and his colleagues are responding to the changing NHS environment. From system pressures and financial constraints to prescribing priorities and ser...
- Nov 12, 202544 min
First to Market: Unlocking Switzerland’s Pharma Potential
Send us Fan Mail What makes Switzerland a compelling first-launch market for Pharma? How does its healthcare system compare to other European countries? What do manufacturers need to know about reimbursement, pricing, and evidence requirements? How might the evolving Joint Clinical Assessment (JCA) landscape influence launch sequencing? This episode explores Switzerland’s potential as an early launch market. In this session, Louise Maddison (Senior Consultant – Global Pricing and Market Acc...
- Oct 13, 20251h 0m
Q&A Webinar: The Evolving NHS Landscape in England – From Policy to Practice
Send us Fan Mail In this NHS Whispers live Q&A webinar, Katie Mulholland (Senior Consultant, UK Market Access, Petauri Evidence) speaks to: - Sarah Everest Ford (Programme Director, Health and Care Partnership) - Patrick McGee (Deputy Programme Director for Pathology, Lancashire & South Cumbria) - Prof. Phil Richardson (Former Dorset ICS System Commissioning Director; now Chief Innovation Officer, Petauri Evidence) Together, they explore the implications of changing...
- Jul 18, 202552 min
Global Pricing and Market Access – Strategies for Success in an Evolving Landscape
Send us Fan Mail Uncover the forces driving change in global pricing and access In this expert-led discussion we explore the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA). At Petauri Evidence, our Global Pricing and Market Access Team are growing to meet the increasing complexity of global launch and access, bringing together fresh perspectives and decades of real-world experience. In this episode, our experts, Clare Foy and Adam Brow...
- Jun 3, 202533 min
Transforming Global Market Access: Smarter Resource Management with Local Affiliates
Send us Fan Mail Discover a smarter way to manage and share market access resources with local affiliates Are your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? In this webinar we discussed how a centralised platform can streamline resource sharing, ensure access to nationally-relevant evidence, and put the resources your local affiliates need right at their fingertips. The webinar features a conversation with Tim Styche (Market Acc...
- Apr 29, 202559 min
Communicating value to US Payers: Insights for Pharma and Medtech
Send us Fan Mail What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging resonates in the US? How do you prepare for launch in a market as diverse as the US? In this Global Whispers episode, Louise Maddison (Senior Consultant – Global Market Access, Petauri Evidence) interviews some of our colleagues from Petauri Advisors who are either former payers, or former industry market access...
About Pharma Market Access Insights - from Petauri Evidence
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Pharma Market Access Insights - from Petauri Evidence in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Pharma Market Access Insights - from Petauri Evidence daily summary?
It's a free AI-powered email that summarizes new episodes of Pharma Market Access Insights - from Petauri Evidence as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Pharma Market Access Insights - from Petauri Evidence podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Pharma Market Access Insights - from Petauri Evidence product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Petauri Evidence.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Pharma Market Access Insights - from Petauri Evidence release new episodes?
Pharma Market Access Insights - from Petauri Evidence publishes monthly. Our AI generates a summary within hours of each new episode.
What topics does Pharma Market Access Insights - from Petauri Evidence cover?
Pharma Market Access Insights - from Petauri Evidence covers topics including Science, Business, Medicine, Fitness, Health & Fitness, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Pharma Market Access Insights - from Petauri Evidence summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.